Advisory Committees

Nature and Basis Statements of Conflict(s) of Interest for Voting Members of FDA Advisory Committee Members

The Agency is revising its procedures regarding the disclosure of conflicts of interest and waivers for voting advisory committee members in order to implement the requirements of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2006) (Nov. 10, 2005). This information is being provided as an interim measure to comply with the requirements of this law.

Meeting of the Cardiovascular and Renal Drugs Advisory Committee
April 25-26, 2006

David DeMets, Ph.D.

• 18 U.S.C. 208 waiver [pdf]
• 18 U.S.C. 208 waiver - General Matters [pdf]
• Acknowledgement and Consent [pdf]

John Flack, M.D.

• 18 U.S.C. 208 waiver – General Matters [pdf]

Robert Harrington, M.D.

• 18 U.S.C. 208 waiver – General Matters [pdf]

William Hiatt, M.D.

• 18 U.S.C. 208 waiver – General Matters [pdf]

Frederick Kaskel, M.D.

• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]

A. Michael Lincoff, M.D.

• 18 U.S.C. 208 waiver – General Matters [pdf]

Thomas Pickering, M.D., D. Phil.

• 18 U.S.C. 208 waiver [pdf]
• 18 U.S.C. 208 waiver – General Matters [pdf]
• Acknowledgement and Consent [pdf]

Ronald Portman, M.D.

• 18 U.S.C. 208 waiver [pdf]
• 18 U.S.C. 208 waiver – General Matters [pdf]
• Acknowledgement and Consent [pdf]

John Teerlink, M.D.

• 18 U.S.C. 208 waiver [pdf]
• 18 U.S.C. 208 waiver – General Matters [pdf]
• Acknowledgement and Consent [pdf]

Page updated: April 7, 2006